These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32903681)

  • 1. Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities.
    Kim TW; Koo SY; Studer L
    Front Cell Dev Biol; 2020; 8():729. PubMed ID: 32903681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.
    Studer L
    Prog Brain Res; 2017; 230():191-212. PubMed ID: 28552229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson's Disease.
    Cha Y; Park TY; Leblanc P; Kim KS
    J Mov Disord; 2023 Jan; 16(1):22-41. PubMed ID: 36628428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.
    de Luzy IR; Niclis JC; Gantner CW; Kauhausen JA; Hunt CPJ; Ermine C; Pouton CW; Thompson LH; Parish CL
    J Neurosci; 2019 Nov; 39(48):9521-9531. PubMed ID: 31641054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges involved in cell therapy for Parkinson's disease using human pluripotent stem cells.
    Moon H; Kim B; Kwon I; Oh Y
    Front Cell Dev Biol; 2023; 11():1288168. PubMed ID: 37886394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.
    Sonntag KC; Song B; Lee N; Jung JH; Cha Y; Leblanc P; Neff C; Kong SW; Carter BS; Schweitzer J; Kim KS
    Prog Neurobiol; 2018 Sep; 168():1-20. PubMed ID: 29653250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson's disease model.
    Xu P; He H; Gao Q; Zhou Y; Wu Z; Zhang X; Sun L; Hu G; Guan Q; You Z; Zhang X; Zheng W; Xiong M; Chen Y
    J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.
    Niclis JC; Gantner CW; Alsanie WF; McDougall SJ; Bye CR; Elefanty AG; Stanley EG; Haynes JM; Pouton CW; Thompson LH; Parish CL
    Stem Cells Transl Med; 2017 Mar; 6(3):937-948. PubMed ID: 28297587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside.
    Wang M; Ling KH; Tan JJ; Lu CB
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of
    Fiorenzano A; Birtele M; Wahlestedt JN; Parmar M
    Heliyon; 2021 Jan; 7(1):e06006. PubMed ID: 33532642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy.
    Silver SE; Barrs RW; Mei Y
    Front Cardiovasc Med; 2021; 8():707890. PubMed ID: 34820426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem Cell Therapy for Parkinson's Disease.
    Han F; Hu B
    Adv Exp Med Biol; 2020; 1266():21-38. PubMed ID: 33105493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use.
    Kim TW; Piao J; Koo SY; Kriks S; Chung SY; Betel D; Socci ND; Choi SJ; Zabierowski S; Dubose BN; Hill EJ; Mosharov EV; Irion S; Tomishima MJ; Tabar V; Studer L
    Cell Stem Cell; 2021 Feb; 28(2):343-355.e5. PubMed ID: 33545081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to make a midbrain dopaminergic neuron.
    Arenas E; Denham M; Villaescusa JC
    Development; 2015 Jun; 142(11):1918-36. PubMed ID: 26015536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.
    Lehnen D; Barral S; Cardoso T; Grealish S; Heuer A; Smiyakin A; Kirkeby A; Kollet J; Cremer H; Parmar M; Bosio A; Knöbel S
    Stem Cell Reports; 2017 Oct; 9(4):1207-1220. PubMed ID: 28943253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dickkopf 3 Promotes the Differentiation of a Rostrolateral Midbrain Dopaminergic Neuronal Subset In Vivo and from Pluripotent Stem Cells In Vitro in the Mouse.
    Fukusumi Y; Meier F; Götz S; Matheus F; Irmler M; Beckervordersandforth R; Faus-Kessler T; Minina E; Rauser B; Zhang J; Arenas E; Andersson E; Niehrs C; Beckers J; Simeone A; Wurst W; Prakash N
    J Neurosci; 2015 Sep; 35(39):13385-401. PubMed ID: 26424886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation of dopaminergic neurons from pluripotent stem cells.
    Studer L
    Prog Brain Res; 2012; 200():243-63. PubMed ID: 23195422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.